Quantification of Smoking-Induced Occupancy of [Beta]^sub 2^-Nicotinic Acetylcholine Receptors: Estimation of Nondisplaceable Binding

5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and spec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of nuclear medicine (1978) 2010-08, Vol.51 (8), p.1226
Hauptverfasser: Esterlis, Irina, Cosgrove, Kelly P, Batis, Jeffery C, Bois, Frederic, Stiklus, Stephanie M, Perkins, Evgenia, Seibyl, John P, Carson, Richard E, Staley, Julie K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:5-^sup 123^I-iodo-85380 (^sup 123^I-5-IA) is used to quantitate high-affinity nicotinic acetylcholine receptors (β^sub 2^-nAChRs) on human SPECT scans. The primary outcome measure is V^sub T^/f^sub P^, the ratio at equilibrium between total tissue concentration (free, nonspecifically bound, and specifically bound) and the free plasma concentration. Nondisplaceable uptake (free plus nonspecific) of ^sup 123^I-5-IA has not been measured in human subjects. Nicotine has high affinity for β^sub 2^*-nAChRs (nAChRs containing the β^sub 2^* subunit, for which * represents other subunits that may also be part of the receptor) and displaces specifically bound ^sup 123^I-5-IA. In this study, we measured nicotine occupancy and nondisplaceable binding in healthy smokers after they had smoked to satiety. Methods: Eleven nicotine-dependent smokers (mean age ± SD, 35.6 ± 14.4 y) completed the study. One subject was excluded from subsequent analyses because of abnormal blood nicotine levels. Subjects abstained from tobacco smoke for 5.3 ± 0.9 d and participated in a 15- to 17-h SPECT scanning day. ^sup 123^I-5-IA was administered by bolus plus constant infusion, with a total injected dose of 361 ± 20 MBq. At approximately 6 h after the start of the infusion, three 30-min SPECT scans and a 15-min transmission-emission scan were acquired to obtain baseline β^sub 2^*-nAChR availability. Subjects then smoked to satiety (2.4 ± 0.7 cigarettes), and arterial (first 40 min) and venous (until study completion) plasma nicotine and cotinine levels were collected. About 1 h after subjects had smoked to satiety, up to six 30-min SPECT scans were acquired. V^sub T^/f^sub P^ data, computed from the tissue and plasma radioactivity measurements from the presmoking baseline and postsmoking scans, were analyzed using the Lassen plot method. Results: Receptor occupancy after subjects had smoked to satiety was 67% ± 9% (range, 55%-80%). Nondisplaceable uptake was estimated as 19.4 ± 5.8 mL*cm^sup -3^ (range. 15-28 mL*cm^sup -3^). Thus, in the thalamus, where mean V^sub T^/f^sub P^ is 93 mL*cm^sup -3^, nondisplaceable binding represents approximately 20% of the total binding. Conclusion: These results are in agreement with previous findings and suggest that when satiating doses of nicotine are administered to smokers, imaging of receptor availability can yield valuable data, such as quantifiable measures of nondisplaceable binding. [PUBLICATION ABSTRACT]
ISSN:0161-5505
1535-5667